| 000 -LEADER |
|---|
| fixed length control field |
a |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20191018151748.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
191018b xxu||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
AIKTC-KRRC |
| Transcribing agency |
AIKTC-KRRC |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| 9 (RLIN) |
9948 |
| Author |
Senthilvel, Chitra Karthikeyini |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Development of Capsules Filled with Phenytoin and Berberine Loaded Nanoparticles- A New Approach to Improve Anticonvulsant Efficacy |
| 250 ## - EDITION STATEMENT |
|---|
| Volume, Issue number |
Vol.53(3), Jul-Sep |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Karnataka |
| Name of publisher, distributor, etc. |
Indian journal of pharmaceutical education and research |
| Year |
2019 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Pagination |
468-479p. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Introduction: Currently used anticonvulsant drugs are not totally effective to control seizures. Phenytoin is a classic instance where its efficiency is inhibited through high metabolization (90%-95%) and back transport through cytochrome P450 and P-glycoprotein, respectively. To explore and attain improved anticonvulsant efficacy combination therapy with nanotechnology has been adopted in this research. Objective: development of nanotechnology-based drug delivery system by filling berberine and phenytoin nanoparticles in capsules. Method: phenytoin and berberine nanoparticles were formulated individually by utilising a solvent evaporation technique and later the mixture is filled in the hard gelatine capsule to create a single-unit dosage. Results: The formulated nanoparticles were evaluated in terms of FTIR and DSC studies, mean particle diameter and zeta-potential, entrapment efficiency and in vitro release. FTIR and DSC studies had proved that formulation components are compatible. SEM report revealed that all the nanoparticles were smooth, spherical in shape and within the size range of 100-500nm. Zeta-potential of phenytoin and berberine nanoparticles was negative (-2.61 and -35.9mV, respectively). In vitro release kinetics was in the accordance with the Higuchi model. The improved efficacy was proved by MES and Histopathological studies. Conclusion: The successfully developed Capsules filled with the Nanoparticles (Combination therapy) exhibited improved efficacy than that of single phenytoin therapy |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| 9 (RLIN) |
4639 |
| Topical term or geographic name entry element |
PHARMACEUTICS |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| 9 (RLIN) |
9949 |
| Co-Author |
Karuppaiyan, Kavitha |
| 773 0# - HOST ITEM ENTRY |
|---|
| International Standard Serial Number |
0019-5464 |
| Place, publisher, and date of publication |
Bengluru Association of Pharmaceutical Teachers of India (APTI) |
| Title |
Indian journal of pharmaceutical education and research |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| URL |
https://www.ijper.org/sites/default/files/IndJPhaEdRes_53_3_468-479.pdf |
| Link text |
Click here |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Koha item type |
Articles Abstract Database |
